L'hôpital Beaujon est un hôpital de l'Assistance publique - Hôpitaux de Paris situé à Clichy. L'hôpital fait partie du Groupe hospitalo-universitaire Nord - Université de Paris de l'AP-HP.

During the past decade, Hopital Beaujon; Gastro Enterologie 1 conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hopital Beaujon; Gastro Enterologie 1" are "Gastric Cancer" (1 trials) and "Hepatitis B, Chronic" (1 trials). Many other conditions were trialed in "Hopital Beaujon; Gastro Enterologie 1" in a lesser frequency.

Most popular intervention types in "Hopital Beaujon; Gastro Enterologie 1" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Taxane" (1 trials) and "trastuzumab emtansine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Beaujon; Gastro Enterologie 1" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Beaujon; Gastro Enterologie 1". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hopital Beaujon; Gastro Enterologie 1, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Beaujon; Gastro Enterologie 1, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".